Murine zcytor17 ligand polypeptides

Details Murine zcytor17 ligand polypeptides Murine zcytor17 ligand polypeptides

2009-01-29

2010-06-22

Mertz, Prema (Department: 1646)

Drug, bio-affecting and body treating compositions

Lymphokine

C435S069500, C435S252300, C435S320100, C435S325000, C530S351000

Reexamination Certificate

active

07740834

ABSTRACT:
The present invention relates to zcytor17lig polynucleotide, polypeptide and anti-zcytor17 antibody molecules. The zcytor17lig is a novel cytokine. The polypeptides may be used within methods for stimulating the immune system, and proliferation and/or development of hematopoietic cells in vitro and in vivo. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.

REFERENCES:
patent: 5925735 (1999-07-01), Baumgartner et al.
patent: 7064186 (2006-06-01), Sprecher et al.
patent: 7507795 (2009-03-01), Sprecher et al.
patent: 2003/0215838 (2003-11-01), Sprecher et al.
patent: 2006/0141579 (2006-06-01), Sprecher et al.
patent: 2006/0188499 (2006-08-01), Leung et al.
patent: 2006/0188500 (2006-08-01), Leung et al.
patent: 2006/0228329 (2006-10-01), Brady et al.
patent: 2006/0275296 (2006-12-01), Siadak et al.
patent: 2007/0077627 (2007-04-01), Sprecher et al.
patent: 2007/0111266 (2007-05-01), Sprecher et al.
patent: 2007/0160610 (2007-07-01), Yao et al.
patent: 2007/0249020 (2007-10-01), Sprecher et al.
patent: 03/060090 (2003-07-01), None
Riken, 1999, (GenBank Acc. No. AV040649).
Riken, 1999, (GenBank Ace. No. AV044404).
Riken, 1999, (GenBank Acc. No. AV268991).
Riken, 1999, (GenBank Acc. No. AV280874).
National Cancer Institute, 1997, (GenBank Acc. No. BF152807).
Riken, 2001, (GenBank Acc. No. BB610257).
Riken, Accession No. AK005939, 1999.
Riken, Accession No. AK005939, Jul. 5, 2001.
National Institutes of Health, 1999, (GenBank Acc. No. CA464033).
Riken, 2002, (GenBank Acc. No. BY706076).
Washington University School of Medicine, 2002, (GenBank Acc. No. CF105870).
RZPD Deutsches Ressourcenzentrum fuer Genomforschung GmbH, 2003, (GenBank Acc. No. BX639332).
Whitehead Institute for Biomedical Research, Mouse Public Genomic Sequence TDB 3482986, Jan. 11, 2001.
Washington University Genome Sequencing Center, Mouse Public Genomic Sequence TDB 16727183, Feb. 24, 2001.
Whitehead Institute for Biomedical Research, Mouse Public Genomic Sequence TDB 10456006, Mar. 14, 2001.
Washington University Genome Sequencing Center, Mouse Public Genomic Sequence TDB 8480322, Jan. 13, 2001.
Whitehead Institute for Biomedical Research, Mouse Public Genomic Sequence TDB 49775248, Oct. 5, 2001.
Whitehead Institute for Biomedical Research, Mouse Public Genomic Sequence TDB 10005090, Mar. 10, 2001.
Whitehead Institute for Biomedical Research, Mouse Public Genomic Sequence TDB 20965871, Mar. 16, 2001.
Whitehead Institute for Biomedical Research, Mouse Public Genomic Sequence TDB 44835892, Sep. 20, 2001.
Washington University Genome Sequencing Center, Mouse Public Genomic Sequence TDB 50734527, Oct. 6, 2001.
Sanger Center, Mouse Public Genomic Sequence TDB 40505897, Aug. 31, 2001.
Sanger Center, Mouse Public Genomic Sequence TDB 1021719, Jan. 4, 2001.
Washington University Genome Sequencing Center, Mouse Public Genomic Sequence TDB 22973884, Apr. 16, 2001.
Abstract from The American Society of Human Genetics Meeting, Nov. 7, 2003 on Gene Structure and Function.
EMBL Accession No. AC048338, Apr. 2000.
EMBL Accession No. AA381907, Apr. 1997.
Dillon et al., “Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice,”Nature Immunology 5(7):752-760, Jul. 2004.
Bilsborough et al., “IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T-cells in patients with atopic dermatitis,”Journal of Allergy and Clinical Immunology, Mosby—Yearly Book, Inc., US 117(2): 418-425, Feb. 7, 2006.
Sonkoly et al., “IL-31: A new link between t-cells and pruritus in atopic skin inflammation”,Journal of Allergy and Clinical Immunology, Mosby—Yearly Book, Inc., US 117(2): 411-417, Feb. 2006.
Takaoka A. et al., “Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis”,Experimental Dermatology, 15(3): 161-167, Mar. 2006.
Takaoka A. et al., “Expression of IL-31 gene transcript in NC/Nga mice with atopic dermatitis”,European Journal of Pharmacology, Amsterdam, NL, 516(2): 180-181, May 31, 2005.
Goding, J.W.,Journal of Immunological Methods vol. 39: 285-308, 1980.
Ständer et al., Hautarzt 54: 413-417, 2003.
Claudy, A., Pathologie et Biologie, L'Expansion Scientifique Francaise, Paris, FR 44(10): 888-894, 1996.
Conti et al., “Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32)”Autoimmunity Reviews 6(3): 131-137, 2007.
Siadak et al., U. S. Appl. No. 11/850,006, filed Sep. 4, 2007.

Affiliated with

Also associated with

Rating

Murine zcytor17 ligand polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Murine zcytor17 ligand polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Murine zcytor17 ligand polypeptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4160967